GlassScriptPhysician profile
Madhavi Chada
NPI 1922212166
$726.39
in general payments reported to CMS, 2019-2025
12 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.64 · 2020: $113 · 2021: $11.49 · 2022: $22.40 · 2023: $140 · 2024: $89.00 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $206.08 | 2022-2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $102.58 | 2025 | Sprint Pns System |
| Medtronic USA, INC. | $101.63 | 2020 | |
| Medtronic, INC. | $89.81 | 2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $71.32 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $52.98 | 2025 | Spinejack, Optablate |
| Si-Bone, INC. | $27.11 | 2024 | |
| Pfizer INC. | $17.00 | 2025 | |
| Globus Medical, INC. | $16.43 | 2025 | Senza |
| Fidia Pharma USA INC. | $15.40 | 2024 | Triluron, Hyalgan, Hymovis |
| Collegium Pharmaceutical, INC. | $14.56 | 2023 | Belbuca |
| Horizon Therapeutics Plc | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madhavi Chada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.